In July 2015, FEB acquired a 45% equity stake in Medisal for Pharmaceuticals Industry L.L.C. (Medisal). Medisal is an Abu Dhabi based pharmaceutical company focused on producing intravenous solutions (IV) and eye drops for local and regional markets. Medisal’s factory has modern production lines with high-specifications. The machinery is able to produce IV solution products at the highest level of accuracy and quality. Medisal commenced its commercial production at the start of 2016. This along with the investment in ADCAN is an investment opportunity to diversify FEB’s investments in the health sector in UAE.